Breaking AI & Tech News Analyzed

The Agentic Leap: Codex Goes BackgroundOpenAI is intensifying its rivalry with Anthropic by significantly upgrading its Codex tool. The latest update transforms Codex from a passive assistant into an active, autonomous agent capable of operating in the background of a user's desktop. This allows the AI to open applications, click, and type without interrupting the user's primary workflow.Parallel Operation: Codex can now run multiple agents simultaneously on a Mac, handling auxiliary tasks like iterating on frontend changes or testing apps while the user focuses on top-level projects.Browser Control: A new in-app browser feature enables Codex to issue commands and execute tasks on specific web applications, with plans to eventually command the browser fully beyond localhost.Memory and Context: The 'memory' feature allows Codex to recall previous work sessions, generating important context about how a specific user works to improve future assistance.Image Generation: Codex has gained the ability to generate product concepts, slide visuals, and mockups, expanding its utility beyond pure code.Expanded Plugin Ecosystem: The tool now supports 111 plug-in integrations, including tools like CodeRabbit and GitLab Issues, allowing it to handle clerical work across Slack and Google Calendar.Enterprise Integration and Pricing StrategyThe update is not just about features; it is a calculated business move designed to capture enterprise workflows. By offering a new pay-as-you-go pricing option for ChatGPT Business and Enterprise customers, OpenAI is lowering the barrier to entry for corporate adoption of these advanced agentic tools.The sheer volume of integrations—111 plugins—serves as a critical data point. It demonstrates OpenAI's strategy to make Codex a central hub for corporate productivity, capable of bridging the gap between coding and general administrative tasks.Strategic Pivot: From Consumer Tools to Corporate AutomationThis development marks a clear shift in OpenAI's strategy. After a period of focus on consumer-facing tools like Sora 2, the company is retreating from the consumer market to double down on enterprise capabilities. This aligns with the broader industry trend of moving from simple chatbots to autonomous agents that can execute complex workflows.The Future of Autonomous Coding AssistantsAs OpenAI and Anthropic battle for supremacy, the definition of a 'coding assistant' is changing. We are moving toward a future where AI agents are not just suggestions but active participants in the development lifecycle, capable of managing entire workflows autonomously. The winner of this war will likely be the provider that best integrates these agents into existing corporate infrastructure.

Caro Claire Burke's Yesteryear had all the makings of a thought-provoking novel: a tradwife protagonist who wakes up in the pioneer days and finds that traditional wifedom is not as glamorous as her social media persona had suggested. The premise is genius, and the protagonist Natalie's biting and occasionally hilarious voice makes the novel zip along.However, as the story progresses, it becomes clear that Burke has failed to create a convincing mother figure in Natalie, and the novel's exploration of pronatalism and traditional Christian values feels shallow and cliched. The author's decision to remove politics almost entirely from the narrative is also a major omission, particularly given the current cultural climate.The novel's main drive becomes resolving the mystery of Natalie's situation - has she really time travelled, or is this an awful reality TV show? - to the detriment of more profound concerns. Burke's treatment of birth injury and child disability as a plot point is also shockingly cack-handed and feels cynical and underresearched.Overall, Yesteryear is a disappointing novel that fails to live up to its promise. Despite its talented author, the book feels like a lesson in not allowing a fun premise to get in the way of a good story.

Bayern Munich and Real Madrid treated fans to an exhilarating encounter in the Champions League, showcasing exceptional skill and drama. The match at the Allianz Arena was a thrilling contest that included slapstick goalkeeping, a fluctuating scoreline, and near-misses. The game took a decisive turn when Eduardo Camavinga was sent off for Real Madrid in the 86th minute, allowing Bayern to score the crucial goals that sealed their victory. The match ended with several red cards and heated post-match exchanges, including Arda Güler and coach Álvaro Arbeloa being ejected for their reactions.Bayern's victory was hailed as a significant achievement by their coach, Vincent Kompany, who likened it to one of his greatest triumphs. The win sets up a semi-final clash with PSG, a challenge Kompany is eager to embrace. Meanwhile, Real Madrid's post-match meltdown and disputes over refereeing decisions added to the drama of the evening.

Big Mood returns for a second season on Channel 4, aiming to blend a serious look at bipolar disorder with broad‑scale comedy. Lead actress Nicola Coughlan reprises Maggie, now emerging from a harrowing episode of lithium poisoning that left her hallucinating and confused. The debut series introduced Maggie in the throes of a manic episode, followed by a depressive crash after she stopped her medication to protect her creative output. While the first season earned praise for its insightful depiction of mental illness, the new installment quickly pivots toward slapstick scenarios – from a militant maid of honour to a secret‑husband extortion plot – that dilute the original emotional weight. Central to the drama is Maggie’s strained bond with best friend Eddie, played by Lydia West. Their friendship, already intense in season one, becomes increasingly implausible as Eddie abandons London for California without explanation. In season two, Eddie resurfaces under the control of a dubious wellness guru named Whitney, who has siphoned her finances and seeks to erase any lingering connection with Maggie. Rather than deepening the exploration of mental health, the series now focuses on a far‑cical showdown between the two women. Maggie, now in a “stable girl” routine of retinol and Hello Fresh meals, obsessively attempts to expose Whitney as a fraud, enlisting Eddie’s friend Will – a character described as “incorrigibly nice” yet treated with contempt by both protagonists. The tonal shift raises questions about the show’s core ambition. While Coughlan delivers an empathetic performance that captures Maggie’s inner turmoil, the surrounding plotlines feel disjointed and at times toxic, especially in the portrayal of the once‑intoxicating platonic romance that now appears more destructive than supportive. Humor, inherently subjective, may still resonate with viewers who appreciate the series’ millennial‑centric chaos. However, the blend of “knockabout farce” with moments of genuine drama feels uneven, suggesting that the show’s initial promise of a heartfelt, realistic bipolar narrative has been eclipsed by over‑reaching comedic contrivances. In conclusion, Big Mood season two struggles to reconcile its dual aims. The ambitious premise that once offered a nuanced look at mental illness now feels buried beneath a barrage of gimmicks, leaving audiences to wonder whether it’s time for the characters – and perhaps the series itself – to move on.

Comedian Phil Ellis has taken a unique approach with his new show 'Bath Mat', embracing his midlife failures and inviting the audience to join in on the laughter. The show features a hype-man, played by fellow comedian Tom Short, who sets the tone with a list of Ellis's non-achievements. Ellis' recent move back in with his parents and his struggles with singleness, balding, and financial struggles are all fair game for comedy. The show is a raucous laugh-along, with Ellis straw-polling his observations with the audience and laughing throughout. While the show has its moments, it lacks the concentrated hits of Ellis' previous work. The structure is loose, with barely related routines and more emphasis on standup than antics. Sections like the chat about roadkill and luxury pet treatment feel more like 'all-in-it-together bants' than precision-focused comedy. However, Ellis' ability to find humor in his own failures and celebrate the ramshackle is part of his charm. Fans of his chaotic kids' show 'Funz and Gamez' will appreciate his skill in creating a diffuse but entertaining show. The titular routine, where Ellis canvasses the crowd about bath mats, is a highlight, triggering a lively and entertaining response. The show's humor is rooted in Ellis' willingness to poke fun at himself, sharing amusing snaps from his childhood photo album and tales of duff gigs. While not all routines earn the hype-man's exclamation points, that's part of the point – Ellis glories in the ramshackle and finds humor in his own crapness.

Recent talks in Islamabad between Washington and Tehran collapsed, reflecting the stark mismatch between the United States' 15‑point proposal and Iran's 10‑point counter‑offer. The brief negotiations, led by U.S. Vice‑President JD Vance, failed to bridge core disagreements on nuclear policy and regional security. Vance attributed the breakdown to Iran's outright rejection of U.S. terms, while President Donald Trump responded by imposing a naval blockade of the Strait of Hormuz. Such a blockade is legally an act of war, raising the specter of Iranian retaliation against Gulf monarchies and a sharp spike in global oil, diesel, and LNG prices. Both sides, however, have not ruled out renewed negotiations. Pakistan and Egypt are quietly mediating, recognizing that a renewed conflict would deepen President Trump's domestic challenges—rising inflation, declining poll numbers, and the approaching midterm elections—while also exacerbating Iran's economic hardship and social unrest. The proposed diplomatic framework focuses on three pillars: Limited uranium enrichment: The U.S. would acknowledge Iran's right, under the Non‑Proliferation Treaty, to enrich uranium for peaceful purposes, capping enrichment at 3.67% (the 2015 JCPOA limit). Monitoring would be conducted by the IAEA through electronic and on‑site inspections, with a potential 20‑year renewable agreement. Sanctions relief and asset release: In exchange for Iran dropping its demand for war reparations, the United States would lift primary and secondary sanctions and unfreeze all Iranian assets. Additionally, Iran would be authorized to levy a $2 million fee per oil tanker transiting Hormuz, shared with Oman, provided it guarantees innocent passage under a multinational oversight coalition that includes Russia and China. Security guarantees: Iran would issue a written pledge not to develop nuclear weapons, echoing the late Ayatollah Ali Khamenei’s injunction. Simultaneously, the U.S. and UN Security Council would endorse a non‑aggression pact between the two nations, with parallel agreements possible for Gulf states. For the plan to succeed, three conditions must be met: Washington must make genuine concessions; President Trump must extend the 22 April cease‑fire deadline and allow sufficient time for complex negotiations; and any Israeli offensive against Iran must be avoided, as it would jeopardize the entire process. Rajan Menon, professor emeritus of international relations at CUNY’s Powell School and senior research fellow at Columbia University’s Saltzman Institute, outlines this pragmatic approach as a means to avert a full‑scale war and secure a durable peace in the Middle East.

A recent Cochrane review analyzing 17 clinical trials involving over 20,000 people with mild cognitive impairment or dementia has concluded that anti-amyloid drugs have a 'trivial' effect on cognition and dementia severity over 18 months.The review, which assessed seven anti-amyloid drugs, found that improvements in functional ability were 'small at best' and that the drugs caused more swelling and bleeding in the brain than the placebo.The findings are a blow to the new wave of drugs designed to slow Alzheimer's by clearing clumps of amyloid protein that build up in the brain. Despite initial hype, with some regulators approving drugs like lcanemab and donanemab, many countries have stopped short of providing them through public health services due to concerns over their effectiveness and cost.Critics of the review argue that it combines results from older, failed drugs with those from newer, more effective medicines, which may skew the conclusions. However, the review's authors defend their approach, stating that all the drugs aimed to remove amyloid from the brain and assessed the impact on patients in a similar way.The review's lead author, Edo Richard, notes that the effect sizes are too small for patients and caregivers to notice, and that the drugs are also 'burdensome' due to the need for regular intravenous drug infusions and MRI scans.Experts in the field, such as Robert Howard, express concerns that the drugs may not truly alter the course of Alzheimer's, and that it's unfair to raise expectations in patients. Meanwhile, Alzheimer's Research UK argues that the review's conclusions are limited by its methodology and that anti-amyloid treatments will not be the whole answer to curing Alzheimer's.

A Pakistani delegation headed by Army Chief General Asim Munir arrived in Tehran on Wednesday, bearing a fresh message from Washington and urging the launch of a second round of negotiations between the United States and Iran. The effort comes as the two‑week ceasefire that halted hostilities last week is set to expire on April 22, leaving a narrow window to end a war that has claimed more than 4,000 lives across the Middle East, primarily in Iran and Lebanon. The initial round of talks, held in Islamabad on April 11‑12, marked the most significant direct engagement between Washington and Tehran in decades. Mediated by Pakistan, the sessions lasted over 20 hours and featured both indirect and direct exchanges between U.S. Vice President JD Vance and senior Iranian officials led by Parliament Speaker Mohammad Bagher Ghalibaf. Despite covering core issues—nuclear programme, sanctions relief, frozen assets and control of the Strait of Hormuz—the talks concluded without a memorandum, with Vance asserting that Iran “did not accept our terms” and that the U.S. requires a “fundamental commitment” to forego nuclear weapons. President Donald Trump has described the conflict as “very close to being over” and hinted that a second round could resume within days, possibly in Islamabad. However, Pakistan’s Prime Minister Shehbaz Sharif is currently on a four‑day tour of Saudi Arabia, Qatar and Turkey to rally regional backing, making a rapid return to Islamabad uncertain. U.S. officials have offered an “in‑principle” agreement to extend the ceasefire, yet a Reuters‑cited source confirmed that Washington has not formally committed to an extension. Meanwhile, Turkish President Recep Tayyip Erdogan expressed optimism, stating that “there can be no negotiating with clenched fists.” Key sticking points remain: Nuclear programme: The United States and Israel demand a complete halt to uranium enrichment, accusing Iran of weaponization despite a lack of public evidence. Iran maintains its enrichment is for civilian use and cites its obligations under the 1970 Non‑Proliferation Treaty. Strait of Hormuz: One‑fifth of global oil and LNG passes through this chokepoint. Since the February strikes, shipping through the strait has dropped by 95 %. Iran permits passage for “non‑hostile” vessels and seeks the right to levy tolls, while the U.S. insists on unrestricted navigation. Lebanon/Hezbollah: Iran demands that Israel cease its offensive against Hezbollah. While Tehran claims the ceasefire covers Lebanon, both the United States and Israel reject this, and Israel continues attacks on Hezbollah positions. Complicating the diplomatic landscape, President Trump announced a naval blockade of Iranian ports, adding pressure on Tehran and potentially hindering any imminent talks. With the ceasefire deadline looming and regional actors issuing mixed signals, the prospects for a renewed U.S.–Iran dialogue hinge on whether Pakistan can secure a consensus among the parties before the window closes.

Marwan Barghouti, a prominent Palestinian leader and senior figure in President Mahmoud Abbas' Fatah movement, has been subjected to a series of violent assaults while serving a life sentence in Israeli prisons since 2002.According to his lawyer, Ben Marmarelli, Barghouti experienced three assaults over March and April, indicating a pattern of escalating violations. On April 8, he was severely beaten in Ganot Prison, left to bleed, and denied medical attention.On March 25, Barghouti was assaulted while being transferred from Megiddo Prison to Ganot. A day earlier, guards stormed his cell with a dog, forcing him to lie on the floor, and then the dog repeatedly attacked him.The conditions of his captivity have been described as harsh and inhumane, with Marmarelli and Barghouti forced to communicate through a glass partition. Despite this, Barghouti remains sharp-minded, focused, and fully engaged in following events outside the prison.Barghouti, regarded as a likely key player in the creation of a Palestinian state due to his ability to unite various political factions, is serving five life sentences for alleged attacks during the second Intifada.His treatment has raised concerns, particularly with a new Israeli law approving the one-sided use of the death penalty targeting Palestinians, which has sparked fears of a mass execution of captives held on 'terror' charges.